Dystrophin involvement in peripheral circadian SRF signalling (2021)
Attributed to:
Antisense Oligonucleotide Therapy for Neuromuscular Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202101014
PubMed Identifier: 34389686
Publication URI: http://europepmc.org/abstract/MED/34389686
Type: Journal Article/Review
Parent Publication: Life Science Alliance
Issue: 10
ISSN: 2575-1077